[免疫疗法:胃癌革命性治疗的进展和挑战]
A N Shi1, Y B Zhou1, G H Wang1
1Department of Gastrointestinal Surgery,Affiliated Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology, Wuhan 430030, China.
Zhonghua wai ke za zhi [Chinese journal of surgery]
|May 30, 2025
概括
免疫疗法为晚期胃癌提供了新的希望,这是癌症死亡的主要原因. 本综述探讨了免疫检查点抑制剂,CAR-T疗法和用于个性化胃癌治疗的癌症疫苗的最新进展.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 胃癌是全球癌症发病率和死亡率的主要原因之一.
- 晚期诊断是常见的,由于非特异性的早期症状.
- 瘤异质性限制了传统治疗的有效性,导致患者的预后不佳.
研究的目的:
- 审查晚期胃癌免疫疗法的最新进展.
- 讨论新的治疗策略,包括免疫检查点抑制剂,CAR-T疗法和癌症疫苗.
- 突出挑战,并建议胃癌免疫疗法研究的未来方向.
主要方法:
- 关于胃癌免疫疗法的最新研究的文献综述.
- 分析新兴的治疗方法及其临床影响.
- 综合当前的挑战和未来的研究机会.
主要成果:
- 免疫疗法代表了向个性化和精确的胃癌治疗的范式转变.
- 在免疫检查点抑制剂,CAR-T疗法和癌症疫苗方面取得了重大进展.
- 尽管取得了进展,但在优化疗效和克服耐药性方面仍然存在挑战.
结论:
- 免疫疗法对改善晚期胃癌的结果具有显著的前景.
- 需要进一步的研究来应对现有的挑战,并充分发挥这些新型治疗的潜力.
- 本综述为推进胃癌护理中的免疫疗法策略提供了见解.
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Cancer Vaccines
522
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
522
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Gastritis-I: Introduction and Types
1.0K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
1.0K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


